Showing results (41-50 of 332) with videos related to

Sort By:
Pageof 34
Microbiology and Immunology|January 1, 1991
The 106-kilobase plasmid of Salmonella braenderup and the 100-kilobase plasmid of Salmonella typhimurium are not necessary for the pathogenicity in experimental modelsS Horiuchi, N Goto, Y Inagaki, et al.
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|October 1, 1991
[In vitro antimicrobial activity of rokitamycin, a macrolide antibacterial agent, against clinically isolated strains of Campylobacter and other enteritis-causing bacteria]S Horiuchi, Y Inagaki, T Chida, et al.
Oral Diseases|August 8, 2014
Advanced glycation end products increase expression of S100A8 and A9 via RAGE-MAPK in rat dental pulp cellsY Nakajima, Y Inagaki, J Kido, et al.
The Journal of Investigative Dermatology|July 1, 1991
Protooncogene (C-Myc) expression in the infiltrating cells of lesional skin from patients with systemic lupus erythematosusY Inagaki, Y Yoshida, Y Hamasaki, et al.
The Journal of Antimicrobial Chemotherapy|October 1, 1989
In-vitro activity of DR-3355, an optically active isomer of ofloxacin, against bacterial pathogens associated with travellers' diarrhoeaY Inagaki, S Horiuchi, T Une, et al.
The Japanese Journal of Antibiotics|October 1, 1992
[Effect of DQ-2556, a new cephalosporin derivative, on fecal microflora]Y Inagaki, T Chida, R Nakaya, et al.
Gene|February 22, 1996
Cloning of the Mycoplasma capricolum gene encoding peptide-chain release factorY Inagaki, Y Bessho, H Hori, et al.
FEBS Letters|March 27, 1995
Substrate-induced acceleration of N-ethylmaleimide reaction with the Cys-65 mutant of the transposon Tn10-encoded metal-tetracycline/H+ antiporter depends on the interaction of Asp-66 with the substrateT Kimura, Y Inagaki, T Sawai, et al.
Journal of Hepato-Biliary-Pancreatic Surgery|February 17, 2001
Hepatic encephalopathy caused by congenital extrahepatic portosystemic venous shuntY Ishii, Y Inagaki, K Hirai, et al.
Kaku Igaku. the Japanese Journal of Nuclear Medicine|November 1, 1992
[Usefulness of 18F-fluorodeoxyglucose positron emission tomography for evaluating myocardial viability in old myocardial infarction]H Niwayama, K Yoshida, Y Masuda, et al.
Pageof 34